Kurma Partners
Investor profile | Builders Republic
About
Kurma Partners is a major European Venture Capital firm strictly specialized in Life Sciences. Founded in 2009, it is renowned for its "Company Creation" model: rather than just selecting existing startups, Kurma actively partners with top academic research centers (like Institut Pasteur or CNRS) to identify scientific breakthroughs and build companies from scratch around them. Since 2024, Kurma has been fully integrated into the Eurazeo group (as their dedicated Healthcare arm), giving them increased financial firepower while maintaining their operational independence. They operate three distinct strategies: Biofund (Therapeutics), Diagnostics (Digital Health & Dx), and Growth (Late-stage scale-ups).
Key facts
- Type
- Venture Capital
- Stages
- Pre-Seed,Seed,Series A,Series B,Growth
- Sectors
- Healthcare,Digital health
- Headquarters
- France
- Offices
- Paris,Munich
- Geographic focus
- France,Europe
- Lead / Follow
- Lead / co-lead
- Ticket size
- 2M€ – 10M€
- Assets under management
- 890M€
- Founded
- 2009
Track record
- Portfolio companies: 52
- Total investments: 72
- Exits: 8
- Unicorns: 2
Notable investments in France
Imcheck Therapeutics, Charles, Ganymed Robotics
Key differentiators
Sector Specialist,Multi-stage,PE-backed,Company Builder